Clinical Trial Update: Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects [Phase 2]

View source ↗

Summary

Phase 2 study of MG-ZG122 in asthma shows the trial is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MG-ZG122

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Bronchial Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING